XASX
DVL
Market cap25mUSD
Jul 10, Last price
0.03AUD
1D
0.00%
1Q
15.38%
Jan 2017
-94.23%
IPO
-92.46%
Name
dorsaVi Ltd
Chart & Performance
P/E
—
P/S
32.80
EPS
—
Div Yield, %
—
Shrs. gr., 5y
24.91%
Rev. gr., 5y
-10.97%
Revenues
1m
-13.40%
Net income
-2m
L+21.66%
CFO
-957k
L+59.23%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMove+, offering comprehensive solutions for both clinical and athletic applications. For workplace safety, dorsaVi provides ViSafe, a wearable sensor system engineered to track, analyze, and report on workforce movements, highlighting and pinpointing unsafe practices that contribute to occupational injuries. This is complemented by myViSafe technology, which enables organizations and on-site clinicians to identify, reduce, and prevent injury risks in the workplace, fostering positive behavioral changes. Additionally, the company offers ViPerform, a wearable and wireless movement sensor technology that supplies objective data for assessing the likelihood of sports injuries and guiding effective athletic training and recovery programs. dorsaVi also delivers telehealth solutions and professional suites to its clients.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||